A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

What makes this tool innovative is its ability to detect subtle brain activity patterns often invisible to the human eye and ...

Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

Vascular dementia is the second most common type of dementia after Alzheimer’s disease. It happens when blood flow to the brain is reduced or blocked, usually due to strokes or damage to small blood ...

Learn how to manage dementia and heart disease simultaneously. Discover medication tips, lifestyle changes, and care strategies for dual conditions.

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a leading Phase III autologous stem cell therapy company and Mr. Croom Lawrence ...

Dementia is a condition that causes a gradual loss of memory, thinking, and problem-solving abilities. It can affect daily life and make it hard for people to live independently. Many people wonder if ...

Sparse Data on Systemic Treatments and Psoriasis. Several international reports have linked psoriasis with dementia, including a 2019 study that found an elevated risk associated with the skin ...